News

Alpha Pro Tech, Ltd. Announces First Quarter 2022 Financial Results

Building Supply Segment Sales Increased 22.7% to a record $10.2 MillionNet sales for the first quarter of 2022 were $17.7…

2 years ago

Faculty Opinions Makes the Insights and Article Recommendations from its Global Network of Life Sciences and Medical Experts Free-to-access

Faculty Opinions, an H1 community, opens up its content by providing free access to 235,000+ research article recommendations in its…

2 years ago

Revolutionary eSight 4 Vision Assistance Device to be Showcased at Retina World Congress

Optical enhancement company attends conference with eSight 4 user to demonstrate the technology and discuss the future of vision techFORT…

2 years ago

Syneos Health Leaders Recognized by HBA

Healthcare Businesswomen’s Association Spotlights Kasey Boynton and Feni Komline for Biopharma Industry ImpactMORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Reverence Emerges from Stealth, Introduces Digital Health Platform to Operationalize Clinically Effective Home-Based Care at Scale

The company launches with $9.5M in initial funding led by Target GlobalNEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Reverence,…

2 years ago

XIL Health Named to Inc. Magazine’s 2022 Best Workplaces List

The women-led healthtech company is recognized for its culture that focuses on the mental, emotional, physical and financial well-being of…

2 years ago

AXIM Biotechnologies Develops Novel Tear Sample Collector System, Files Patent Application

SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an…

2 years ago

Coherus BioSciences Management to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will…

2 years ago

Outlook Therapeutics to Participate in Retina World Congress 2022

ISELIN, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop…

2 years ago

NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Obsessive-Compulsive Disorder

Clearance allows for more access to non-drug, noninvasive treatment for patients suffering from MDD or OCDMALVERN, Pa., May 10, 2022…

2 years ago